Clobetasol propionate 0.05% ointment

DRUG5 trials

Sponsors

LEO Pharma, Medstar Health Research Institute, Prof. Dr. Volker Viereck, Dr. Jose N. Rodriguez Memorial Hospital and Sanitarium

Conditions

Chronic Skin DiseaseConnective Tissue DiseasesPilot StudyPsoriasisSkin Tissue DiseasesVulvar Lichen Sclerosus

Early Phase 1

Topical 1% Methotrexate Gel Versus Clobetasol Propionate in Patients With Psoriasis

CompletedNCT06555497

Dr. Jose N. Rodriguez Memorial Hospital and SanitariumPilot Study, Psoriasis

Start: 2022-01-01End: 2023-12-31Updated: 2024-08-16

Phase 1

A Clinical Trial to Assess the Potential of LEO 130852A Gel to Reduce Steroid Induced Skin Atrophy on Healthy Skin

CompletedNCT02392130

LEO PharmaConnective Tissue Diseases, Skin Tissue Diseases

Start: 2015-03-31End: 2015-06-30Updated: 2025-02-24

Phase 3

Clobetasol Propionate Versus Fractionated Carbon Dioxide Laser for the Treatment of Lichen Sclerosus

CompletedNCT02573883

Medstar Health Research InstituteVulvar Lichen Sclerosus

Start: 2015-10-31End: 2019-09-30Updated: 2021-10-12

Phase 4

Fractionated CO2 Laser With and Without Clobetasol for Treatment of Vulvar Lichen Sclerosus

CompletedNCT04951206

Medstar Health Research InstituteVulvar Lichen Sclerosus

Start: 2022-03-01End: 2025-04-25Updated: 2025-06-05

Unknown Phase

Clinical Trial to Demonstrate That the Dual Laser Therapy is Effective for the Treatment of Vulvar Lichen Sclerosus

CompletedNCT03926299

Prof. Dr. Volker ViereckChronic Skin Disease, Vulvar Lichen Sclerosus

Start: 2019-07-15End: 2024-07-30Updated: 2026-03-23

Related Papers

One-year outcome after laser treatment of vulvar lichen sclerosus: a prospective observational trial

Archives of Gynecology and Obstetrics2026-07-01

Nd:YAG/Er:YAG dual laser vs. topical steroid to treat vulvar lichen sclerosus: study protocol of a randomized controlled trial.

2023-05-055 citations

Clobetasol Compared With Fractionated Carbon Dioxide Laser for Lichen Sclerosus

Obstetrics and Gynecology2021-05-0436 citations